5-Fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer

Pancreas

Volumn 30, Issue 3, 2005, Pages 223-226

  Takamori, Hiroshi ^a   Kanemitsu, Keiichiro ^a   Tsuji, Tatsuya ^a   Tanaka, Hiroshi ^a   Chikamoto, Akira ^a   Nakahara, Osamu ^a   Hiraoka, Takehisa ^a   Ikeda, Osamu ^a   Kudo, Koichi ^a   Imuta, Masanori ^a   Yamashita, Yasuyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

5 fluorouracil intra arterial infusion; Distant metastases; Unresectable pancreatic cancer

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; BILIARY TRACT DRAINAGE; BRAIN INFARCTION; CANCER COMBINATION CHEMOTHERAPY; CHOLANGITIS; CLINICAL ARTICLE; DUODENUM ULCER; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MALE; METASTASIS; NAUSEA; NEUTROPENIA; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VISUAL FIELD DEFECT;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 20144369072     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000158025.46172.ae     Document Type: Article

References (13)

1. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80:1830-1837.
2. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
3. Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefits with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial. J Clin Oncol. 1997;15: 2403-2413.
4. Schulz L, Schalhorn A, Wilmanns W, et al. Synergistic interactions of gemcitabine and 5-fluorouracil in colon cancer cells. Proc Am Soc Clin Oncol. 1998;17:251a.
5. Zanon C, Alabiso O, Grosso M, et al. Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer. Int J Pancreatol. 2000;27: 225-233.
6. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 1989;76:545-548.
7. Ackermann NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 1974;75: 589-596.
8. Kemeny NE. Regional chemotherapy of colorectal cancer. Eur J Cancer. 1995;31A:1271-1276.
9. Kerr DJ, McArdle CS, Ledermann J. et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361:368-373.
10. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randamized trial. J Clin Oncol. 1992;10: 1112-1118.
11. Griffin JF, Smally SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990;66:56-61.
12. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer. 2001;30:147-160.
13. Heinrich S, Petrowsky H, Schwinnen I, et al. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery. 2003;133:40-48.